Skip to content

Clinical trials

Completed Hepatitis, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis, Chronic Status: Completed Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20051
20061
20082
20093
20101
20111
20121
20135
20141
20151
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)6
Gilead Sciences4
Pfizer3
GlaxoSmithKline2
Novartis Pharmaceuticals2
Bachir Taouli1
Bristol-Myers Squibb1
National Cancer Institute (NCI)1
Timothy Morgan, MD1
University of Minnesota1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis, Chronic24
Hepatitis12
Hepatitis C12
Liver Diseases11
Hepatitis C, Chronic10
Hepatitis, Viral, Human7
Digestive System Diseases6
Virus Diseases6
Fibrosis5
RNA Virus Infections5

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.